Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Int. braz. j. urol ; 44(4): 704-708, July-Aug. 2018. tab
Artículo en Inglés | LILACS | ID: biblio-954066

RESUMEN

ABSTRACT Aim: Although prostate cancer (PCa) is the most common cancer type in men, a replaceable risk factor has not yet been established. In our study, we assessed the relationship between the number of sexual partners, age of first sexual experience and age of first masturbation and prostate cancer incidence. Materials and Methods: In Ordu University Department of Urology between January 2013 and September 2016, in PSA elevation and rectal examination, patients with prostate biopsy were evaluated due to nodule palpation in the prostate. At younger ages and at present, their first masturbation ages, first sexual debut ages, and total sexual partner numbers were recorded. The correlation between the obtained data and PCa frequency was evaluated. Results: The study included 146 patients with PCa identified on biopsy and 171 patients with benign biopsy results who answered the questions. 66.7% of the ones whose biopsy results were benign and 40.6% of cancer suspects had only one sexual partner. The median number of sexual partners was 1±4 (1-100) in the benign group and 2±6 (1-500) in the malignant group (p=0.039). There was a negative correlation between age of first sexual debut and number of partners (r: −0,479; p <0.001). Conclusion: In our study, it appears that there may be an association between the number of sexual partners and prostate cancer in the patient group with PSA level above 4ng/mL. Avoidance of sexual promiscuity or participation in protected sex may be beneficial to protect against prostate cancer.


Asunto(s)
Humanos , Masculino , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Próstata/etiología , Conducta Sexual/estadística & datos numéricos , Parejas Sexuales , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/sangre , Asunción de Riesgos , Turquía/epidemiología , Biopsia , Incidencia , Factores de Riesgo , Factores de Edad , Antígeno Prostático Específico/sangre , Coito , Estadísticas no Paramétricas , Medición de Riesgo , Mar Negro , Persona de Mediana Edad
3.
Int. braz. j. urol ; 43(5): 887-895, Sept.-Oct. 2017. tab
Artículo en Inglés | LILACS | ID: biblio-892897

RESUMEN

ABSTRACT Aim: URS is a very commonly used procedure for treatment of ureter stones. Increased hydrostatic pressure in the collecting system linked to fluids used during the procedure may cause harmful effects on the kidney. The aim of this study is to determine whether the URS procedure has a negative effect on the kidney by investigating NGAL, KIM-1, FABP and Cys C levels in urine. Material and Methods: This study included 30 patients undergoing ureterorenoscopy (URS) for ureter stones. Urine samples were collected 5 times; before the URS procedure (control) and at 1, 3, 5 and 12 hours following the procedure. NGAL, KIM-1, FBAP and Cys C levels were measured in urine and compared with the control values. Results: The NGAL levels in urine before the procedure and at 1, 3, 5 and 12 hours after the procedure were 34.59±35.34; 62.72±142.32; 47.15±104.48; 45.23±163.16 and 44.99±60.79ng/mL, respectively (p=0.001). Similarly, the urinary KIM-1, FABP and Cys C levels were found to increase compared to control values; however this increase did not reach statistical significance (p >0.05). Conclusions: After the URS procedure, there were important changes in NGAL, FABP, KIM-1 and Cys C levels. These changes reached statistical significance for NGAL, but did not reach significance for the other parameters. In conclusion, the URS procedure significantly affects the kidney; however, this effect disappears over time.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Anciano , Biomarcadores/orina , Cálculos Ureterales/cirugía , Ureteroscopía/métodos , Persona de Mediana Edad , Cálculos Ureterales/orina , Cistatinas/orina , Ureteroscopía/efectos adversos , Proteínas de Unión a Ácidos Grasos/orina , Lipocalina 2/orina , Receptor Celular 1 del Virus de la Hepatitis A/análisis
4.
Int. braz. j. urol ; 43(2): 345-355, Mar.-Apr. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-840833

RESUMEN

ABSTRACT Introduction Sepsis is an inflammatory reaction to bacteria involving the whole body and is a significant cause of mortality and economic costs. The purpose of this research was to determine whether tadalafil exhibits a preventive effect on sepsis in a septic model induced in rats with cecal ligation and puncture (CLP). Materials and Methods Rats were randomly separated into groups, 10 rats in each: (i) a sham (control) group, (ii) an untreated sepsis group, (iii) a sepsis group treated with 5mg/kg tadalafil and (iv) a sepsis group treated with 10mg/kg tadalafil. A polymicrobial sepsis model was induced in rats using CLP. Rats were sacrificed after 16h, and blood and kidney tissues were collected for biochemical and histopathological study. Results Levels of the inflammatory parameter IL-6 decreased significantly in the sepsis groups receiving tadalafil in comparison with the untreated sepsis group (p<0.05). In terms of histopathology, inflammation scores investigated in kidney tissues decreased significantly in the sepsis groups receiving tadalafil compared to the untreated sepsis group (p<0.05). In addition, levels of creatinine and cystatin C measured in septic rats receiving tadalafil were lower by a clear degree than in septic rats (p<0.05). Conclusion In this study, tadalafil exhibited a preventive effect for sepsis-related damage by suppressing inflammation in serum and kidney tissue of septic rats in a polymicrobial sepsis model induced with CLP.


Asunto(s)
Animales , Masculino , Sepsis/complicaciones , Sepsis/prevención & control , Insuficiencia Renal/etiología , Insuficiencia Renal/prevención & control , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Tadalafilo/uso terapéutico , Valores de Referencia , Espectrofotometría , Superóxido Dismutasa/análisis , Calcitonina/sangre , Ensayo de Inmunoadsorción Enzimática , Inmunohistoquímica , Catalasa/análisis , Distribución Aleatoria , Reproducibilidad de los Resultados , Interleucina-6/sangre , Ratas Wistar , Peroxidasa/análisis , Sepsis/patología , Creatinina/sangre , Modelos Animales de Enfermedad , Insuficiencia Renal/patología , Cistatina C/sangre , Riñón/efectos de los fármacos , Riñón/patología , Ligadura , Malondialdehído/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA